Cadence Design Systems Inc vs IDEXX Laboratories, Inc. — how do they compare? Cadence Design Systems Inc trades at $323.09 (market cap $90.20B), while IDEXX Laboratories, Inc. trades at $571.03 (market cap $46.22B). The key difference: Cadence Design Systems Inc is the larger of the two by market cap, and Cadence Design Systems Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| CDNS | IDXX | |
|---|---|---|
Market Cap | $90.20B | $46.22B |
Sector | Technology | Health |
52-Week High | $416.39 | $766.68 |
52-Week Low | $265.66 | $526.44 |
Enterprise Value | $91.41B | $47.12B |
Signals from Pluang's Aura AI — not financial advice
Cadence Design Systems (CDNS) trades at $326.75, down 1.55% amid a bearish technical signal, though strong fundamentals persist with Q2 2026 earnings beating estimates and AI-driven backlog hitting $8.1B. Revenue growth accelerated to 24% year-over-year, while profitability remains robust with 85.87% gross margins. The stock faces near-term pressure from technical indicators but maintains strong analyst support with an $415.11 consensus target.
The outlook remains positive given Cadence's leadership in semiconductor design software and exposure to AI growth, though high valuations (P/E 65.12) and technical bearishness pose risks. Investor sentiment is buoyed by record backlog and raised 2026 guidance, but competition and macroeconomic sensitivity could challenge further upside.
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
Trailing returns across standard periods
Latest headlines on both assets
Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enable system-level analysis and verification solutions. Cadence's comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers, alongside secular digitalization of various end markets, benefits EDA vendors like Cadence.
Read more on CDNS →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →